Recommended for cavity filling
The design and the structural integrity of the dressing allow you to cut the dressing and make it fit to wounds of many sizes, shapes and depths. The dressing will conform to the wound bed, which is important for the wound healing process.
High dressing integrity
The high dressing integrity allows for one-piece removal of the dressing with minimal pain and trauma (1,2).
Minimized risk of leakage and maceration
The superior absorption of Biatain® Alginate (1,2) and the gel formation, which locks the exudate inside the dressing, prevent leakage that can damage the periwound skin.
Documented hemostatic effect
Contrary to hydrofibre dressings, Biatain® Alginate has documented hemostatic effect, i.e. the ability to arrest blood flow in minor bleedings due to the release of calcium ions from the dressing (4,5).
Mode of action
On contact with wound exudate, Biatain® Alginate converts to a soft, cohesive gel that provides an optimal moist wound healing environment (2).
Product composition
Biatain® Alginate is an alginate dressing consisting of 85% alginate and 15% carboxymethylcellulose (CMC).
Usage
Biatain® Alginate can be used on all moderate to heavily exuding partial to full thickness wounds. Biatain® Alginate may assist in supporting the control of minor bleeding in superficial wounds. Biatain® Alginate can be used with compression therapy. Biatain® Alginate should not be used on dry or lightly exuding wounds or to control heavy bleeding. Biatain® Alginate is indicated for pressure ulcers, venous leg ulcers, arterial ulcers, diabetic foot ulcers, donor sites or traumatic wounds.
REFERENCES
1. Thomas S et al. www.dressings.org/TechnicalPublications/PDF/Coloplast-Dressings-Testing-2003-2004.pdf
2. Timmons J. Alginate and hydrofiber dressings. Professional Nurse 1999:14(7).
3. http://www.worldwidewounds.com/1998/june/Alginates-FAQ/alginates-questions.html
4. Segal HC et al. The effects of alginate and non-alginate wound dressings on blood coagolation and platelet activation. Journal of Biomaterials Applications 1998:249-57.
5. Elalamy I and Robert F. Etude in vitro des effets proactivateurs plaquettaires de deux pansements: Alginate pur (Algostéril) et Alginate-CMC (SeaSorb Soft), etude sur plasma riche en plaquettes. CPC France 2007.
Biatain Alginate has a documented hemostatic effect.
Biatain Alginate is ideal for cavity filling.
Unique 3D foam structure for superior absorption
When in contact with exudate, the unique 3D foam structure of Biatain® Ag Non-Adhesive conforms closely to the wound bed for superior absorption – even under compression (5).
Designed to prevent infection
The sustained silver release profile ensures a homogenous distribution of silver ions providing a continuous antibacterial effect during entire wear time (up to 7 days) (6).
Patented with a silver complex with broad antibacterial profile
Independent studies have proven that Biatain® Ag is effective on bacteria commonly found in infected non-healing wounds(3,4). Clinical studies have shown that infected wounds heal faster with Biatain® Ag than with other wound dressings, including other antibacterial dressings (1,2,7).
Continuous antibacterial effect during entire wear time
Due to the sustained silver release profile, there is a continuous antibacterial effect during entire wear time (up to 7 days) (6).
Mode of action
In the presence of exudate, silver is continuously released into the wound bed for up to 7 days.
Composition
Biatain® Ag Non-Adhesive is a soft and flexible absorbent polyurethane foam that is patented with a silver complex homogeneously dispersed throughout the foam matrix.
Usage
Biatain® Ag Non-Adhesive can be used for a wide range of exuding wounds with delayed healing due to bacteria, or where there is a risk of infection, including leg ulcers, pressure injuries, diabetic foot ulcers. second-degree burns, donor sites, postoperative wounds and skin abrasions. Biatain® Ag Non-Adhesive can be used in combination with compression therapy.
REFERENCES
1. Leaper D et al. The use of Biatain® Ag in hard-to-heal venous leg ulcers: Meta-analysis of randomized controlled trials. PLOS ONE 2013: 8(7).
2. Münter KC et al. Effect of a sustained silver releasing dressing on ulcers with delayed healing: the CONTOP study. Journal of Wound Care. 2006:15(5):199-206.
3. Ip M et al. Antimicrobial activities of silver dressings: an in vitro comparison. Journal of Medical Microbiology 2006:55:59-63.
4. Basterzi Y et al. In-vitro comparison of antimicrobial efficacy of various wound dressing materials. Wounds July 2010.
5. Reitzel N & Marburger M. Foam Dressings containing silver tested in vitro for absorption capacity under pressure. EWMA 2009.
6. Buchholz C. An in-vitro comparison of antimicrobial activity. Wounds UK 2009.
7. Scanlon E et al. Cost effective faster wound healing with a sustained silver-releasing foam dressing in delayed healing leg ulcers- a health economic analysis. International Wound Journal 2005:2(2):150-60.
Recommended for cavity filling
The design and the structural integrity of the dressing allow you to cut the dressing and make it fit to wounds of many sizes, shapes and depths. The dressing will conform to the wound bed, which is important for the wound healing process.
High dressing integrity
The high dressing integrity allows for one-piece removal of the dressing with minimal pain and trauma (1,2).
Minimized risk of leakage and maceration
The superior absorption of Biatain® Alginate (1,2) and the gel formation, which locks the exudate inside the dressing, prevent leakage that can damage the periwound skin.
Documented hemostatic effect
Contrary to hydrofibre dressings, Biatain® Alginate has documented hemostatic effect, i.e. the ability to arrest blood flow in minor bleedings due to the release of calcium ions from the dressing (4,5).
Mode of action
On contact with wound exudate, Biatain® Alginate converts to a soft, cohesive gel that provides an optimal moist wound healing environment (2).
Product composition
Biatain® Alginate is an alginate dressing consisting of 85% alginate and 15% carboxymethylcellulose (CMC).
Usage
Biatain® Alginate can be used on all moderate to heavily exuding partial to full thickness wounds. Biatain® Alginate may assist in supporting the control of minor bleeding in superficial wounds. Biatain® Alginate can be used with compression therapy. Biatain® Alginate should not be used on dry or lightly exuding wounds or to control heavy bleeding. Biatain® Alginate is indicated for pressure ulcers, venous leg ulcers, arterial ulcers, diabetic foot ulcers, donor sites or traumatic wounds.
REFERENCES
1. Thomas S et al. www.dressings.org/TechnicalPublications/PDF/Coloplast-Dressings-Testing-2003-2004.pdf
2. Timmons J. Alginate and hydrofiber dressings. Professional Nurse 1999:14(7).
3. http://www.worldwidewounds.com/1998/june/Alginates-FAQ/alginates-questions.html
4. Segal HC et al. The effects of alginate and non-alginate wound dressings on blood coagolation and platelet activation. Journal of Biomaterials Applications 1998:249-57.
5. Elalamy I and Robert F. Etude in vitro des effets proactivateurs plaquettaires de deux pansements: Alginate pur (Algostéril) et Alginate-CMC (SeaSorb Soft), etude sur plasma riche en plaquettes. CPC France 2007.
Biatain Alginate has a documented hemostatic effect.
Biatain Alginate is ideal for cavity filling.
Unique 3D foam structure for superior absorption
When in contact with exudate, the unique 3D foam structure of Biatain® Ag Non-Adhesive conforms closely to the wound bed for superior absorption – even under compression (5).
Designed to prevent infection
The sustained silver release profile ensures a homogenous distribution of silver ions providing a continuous antibacterial effect during entire wear time (up to 7 days) (6).
Patented with a silver complex with broad antibacterial profile
Independent studies have proven that Biatain® Ag is effective on bacteria commonly found in infected non-healing wounds(3,4). Clinical studies have shown that infected wounds heal faster with Biatain® Ag than with other wound dressings, including other antibacterial dressings (1,2,7).
Continuous antibacterial effect during entire wear time
Due to the sustained silver release profile, there is a continuous antibacterial effect during entire wear time (up to 7 days) (6).
Mode of action
In the presence of exudate, silver is continuously released into the wound bed for up to 7 days.
Composition
Biatain® Ag Non-Adhesive is a soft and flexible absorbent polyurethane foam that is patented with a silver complex homogeneously dispersed throughout the foam matrix.
Usage
Biatain® Ag Non-Adhesive can be used for a wide range of exuding wounds with delayed healing due to bacteria, or where there is a risk of infection, including leg ulcers, pressure injuries, diabetic foot ulcers. second-degree burns, donor sites, postoperative wounds and skin abrasions. Biatain® Ag Non-Adhesive can be used in combination with compression therapy.
REFERENCES
1. Leaper D et al. The use of Biatain® Ag in hard-to-heal venous leg ulcers: Meta-analysis of randomized controlled trials. PLOS ONE 2013: 8(7).
2. Münter KC et al. Effect of a sustained silver releasing dressing on ulcers with delayed healing: the CONTOP study. Journal of Wound Care. 2006:15(5):199-206.
3. Ip M et al. Antimicrobial activities of silver dressings: an in vitro comparison. Journal of Medical Microbiology 2006:55:59-63.
4. Basterzi Y et al. In-vitro comparison of antimicrobial efficacy of various wound dressing materials. Wounds July 2010.
5. Reitzel N & Marburger M. Foam Dressings containing silver tested in vitro for absorption capacity under pressure. EWMA 2009.
6. Buchholz C. An in-vitro comparison of antimicrobial activity. Wounds UK 2009.
7. Scanlon E et al. Cost effective faster wound healing with a sustained silver-releasing foam dressing in delayed healing leg ulcers- a health economic analysis. International Wound Journal 2005:2(2):150-60.
